The Cancer Tissue Diagnostics market size is USD 16.9 Bn in 2026.
The Cancer Tissue Diagnostics market is projected to grow at a CAGR of 5% by 2033.
The Cancer Tissue Diagnostics market growth drivers include rising global cancer incidence, advancements in precision medicine and automation, and increasing adoption of digital pathology and AI-based diagnostics.
U.S. is a dominating region for Cancer Tissue Diagnostics market.
Roche Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Agilent Technologies, and Siemens Healthineers are some leading industry players in the Cancer Tissue Diagnostics market.